Yep, just don't see a timeline, which in these kinda stocks is a good fwd looking target for them and investors alike. Only -
"The Company remains well funded to reach its key milestones and will focus its capital on its core R&D
program including clinical evaluation, product manufacturing and commercialisation."
Basically confirming no need for new capital this year.
- Forums
- ASX - By Stock
- AC8
- Ann: December 2019 Quarterly Activities and Cashflow Reports
Ann: December 2019 Quarterly Activities and Cashflow Reports, page-12
-
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online